GCA
PRAH

Gideon Capital Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Gideon Capital Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,494
Closed -$247K – 416
2019
Q3 		$247K Buy
+2,494
New +$248K 0.08% 256
2019
Q1 		– Sell
-5,108
Closed -$470K – 555
2018
Q4 		$470K Buy
5,108
+3,232
+172% +$327K 0.19% 168
2018
Q3 		$207K Buy
+1,876
New +$195K 0.1% 318

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Gideon Capital Advisors's PRAH Position: Q4 2019 in Review

Gideon Capital Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2019, closing a stake of 2,494 shares — an estimated $247K sold.

Gideon Capital Advisors first reported a position in PRAH in Q3 2018 and held it in 3 quarters. The position peaked at $470K in Q4 2018. 345 funds tracked by Wall St. Rank hold PRAH as of Q4 2019.

  • Gideon Capital Advisors reported no remaining PRA Health Sciences, Inc. position as of Q4 2019 after selling out during the quarter.
  • Gideon Capital Advisors sold 2,494 PRA Health Sciences, Inc. shares in Q4 2019, an estimated $247K.
  • Gideon Capital Advisors first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 3 quarters.
  • Gideon Capital Advisors's PRA Health Sciences, Inc. position peaked at $470K in Q4 2018.
  • 345 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2019.

Based on Gideon Capital Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.